Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Search for other papers by Ayako Sato in
Google Scholar
PubMed
Search for other papers by Katsuya Matsuda in
Google Scholar
PubMed
Search for other papers by Takahiro Motoyama in
Google Scholar
PubMed
Al-Farabi Kazakh National University, Almaty City, Republic of Kazakhstan
Search for other papers by Zhanna Mussazhanova in
Google Scholar
PubMed
Search for other papers by Ryota Otsubo in
Google Scholar
PubMed
Search for other papers by Hisayoshi Kondo in
Google Scholar
PubMed
Search for other papers by Yuko Akazawa in
Google Scholar
PubMed
Search for other papers by Miyoko Higuchi in
Google Scholar
PubMed
Search for other papers by Ayana Suzuki in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Takeshi Nagayasu in
Google Scholar
PubMed
Search for other papers by Masahiro Nakashima in
Google Scholar
PubMed
Introduction Thyroid follicular carcinoma (FC) must be differentiated from the more common follicular adenoma (FA). However, it is almost impossible to preoperatively diagnose follicular tumors (FTs) by fine-needle aspiration cytology (FNAC
Search for other papers by Flávia O Valentim in
Google Scholar
PubMed
Search for other papers by Bárbara P Coelho in
Google Scholar
PubMed
Search for other papers by Hélio A Miot in
Google Scholar
PubMed
Search for other papers by Caroline Y Hayashi in
Google Scholar
PubMed
Search for other papers by Danilo T A Jaune in
Google Scholar
PubMed
Search for other papers by Cristiano C Oliveira in
Google Scholar
PubMed
Search for other papers by Mariângela E A Marques in
Google Scholar
PubMed
Search for other papers by José Vicente Tagliarini in
Google Scholar
PubMed
Search for other papers by Emanuel C Castilho in
Google Scholar
PubMed
Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Gláucia M F S Mazeto in
Google Scholar
PubMed
Introduction The differential diagnosis of thyroid follicular lesions includes both benign tumors, such as follicular adenoma (FA) and malignant tumors, such as follicular carcinoma (FC) and follicular variant of papillary carcinoma (FVPC
Search for other papers by Simonetta Piana in
Google Scholar
PubMed
Search for other papers by Eleonora Zanetti in
Google Scholar
PubMed
Search for other papers by Alessandra Bisagni in
Google Scholar
PubMed
Search for other papers by Alessia Ciarrocchi in
Google Scholar
PubMed
Search for other papers by Davide Giordano in
Google Scholar
PubMed
Search for other papers by Federica Torricelli in
Google Scholar
PubMed
Search for other papers by Teresa Rossi in
Google Scholar
PubMed
Search for other papers by Moira Ragazzi in
Google Scholar
PubMed
to be addressed. In particular, the expression profile of this protein within the spectrum of thyroid tumors, benign and malignant, follicular-derived and medullary, has never been consistently investigated ( 23 ). Thus, in this work, we aimed at
Search for other papers by Ashley N Reeb in
Google Scholar
PubMed
Search for other papers by Andrea Ziegler in
Google Scholar
PubMed
Search for other papers by Reigh-Yi Lin in
Google Scholar
PubMed
Introduction Follicular thyroid cancer (FTC) is the second most frequently diagnosed thyroid cancer after papillary thyroid cancer (PTC). About 10,000 cases of FTC are diagnosed annually in the United States, comprising about 10–15% of all
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed
Search for other papers by Daniela Betea in
Google Scholar
PubMed
Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Beatrice Waser in
Google Scholar
PubMed
Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed
Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed
Search for other papers by Emanuel Christ in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
pituitary and thyroid tumors. Immunohistochemistry of the follicular thyroid cancer showed no AIP staining ( Fig. 4 ). Similarly, the pituitary adenoma in Patient 2 had low or absent AIP staining on immunohistochemistry ( Fig. 4 ). Further immunostaining
Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultad de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Tolima, Colombia
Facultad de Ciencias para la Salud, Universidad de Caldas, Manizales, Caldas, Colombia
Search for other papers by Ana P Estrada-Flórez in
Google Scholar
PubMed
Search for other papers by Mabel E Bohórquez in
Google Scholar
PubMed
Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia
Search for other papers by Alejandro Vélez in
Google Scholar
PubMed
Search for other papers by Carlos S Duque in
Google Scholar
PubMed
Search for other papers by Jorge H Donado in
Google Scholar
PubMed
Search for other papers by Gilbert Mateus in
Google Scholar
PubMed
Search for other papers by Cesar Panqueba-Tarazona in
Google Scholar
PubMed
Search for other papers by Guadalupe Polanco-Echeverry in
Google Scholar
PubMed
Search for other papers by Ruta Sahasrabudhe in
Google Scholar
PubMed
Search for other papers by Magdalena Echeverry in
Google Scholar
PubMed
Dinamica IPS, Medellín, Antioquia, Colombia
University of California Davis Comprehensive Cancer Center, Sacramento, California, USA
Fundación de Genética y Genómica, Medellín, Antioquia, Colombia
Search for other papers by Luis G Carvajal-Carmona in
Google Scholar
PubMed
, 5 , 6 ). We have previously shown that Colombian PTC patients have a higher prevalence of indicators of severity and aggressive tumor behavior, such as large size, extra-thyroid extension, and lymph node and distant metastasis, than reported in
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
patients with DTC and is predominantly observed in the lungs and bone ( 3 , 4 , 5 , 6 ). When treating metastatic tumors of differentiated thyroid carcinoma, a favorable prognosis can be expected after radioactive iodine (RAI) therapy after total
Search for other papers by David T Broome in
Google Scholar
PubMed
Search for other papers by Gauri B Gadre in
Google Scholar
PubMed
Search for other papers by Ehsan Fayazzadeh in
Google Scholar
PubMed
Search for other papers by James F Bena in
Google Scholar
PubMed
Search for other papers by Christian Nasr in
Google Scholar
PubMed
(OS) and cancer-specific survival (CSS). Significant risk factors that were identified for a decrease in survival included follicular thyroid cancer, age >45 years ( 8 ), cancer with metastasis to bone ( 5 ), increased tumor size ( 8 ) and tumor size
Search for other papers by Ana Carolina de Jesus Paniza in
Google Scholar
PubMed
Search for other papers by Thais Biude Mendes in
Google Scholar
PubMed
Search for other papers by Matheus Duarte Borges Viana in
Google Scholar
PubMed
Search for other papers by Débora Mota Dias Thomaz in
Google Scholar
PubMed
Search for other papers by Paula B O Chiappini in
Google Scholar
PubMed
Search for other papers by Gabriel A Colozza-Gama in
Google Scholar
PubMed
Search for other papers by Susan Chow Lindsey in
Google Scholar
PubMed
Search for other papers by Marcos Brasilino de Carvalho in
Google Scholar
PubMed
Search for other papers by Venâncio Avancini Ferreira Alves in
Google Scholar
PubMed
Search for other papers by Otavio Curioni in
Google Scholar
PubMed
Department of Microbiology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil
Search for other papers by André Uchimura Bastos in
Google Scholar
PubMed
Search for other papers by Janete Maria Cerutti in
Google Scholar
PubMed
follicular thyroid neoplasm with papillary-like nuclear features (NIFTPs). This distinct entity, which is considered a ‘premalignant’ lesion, was included in the 2017 World Health Organization Classification of Tumors of Endocrine Organs book ( 13 ). However
Search for other papers by Klaudia Zajkowska in
Google Scholar
PubMed
Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed
Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed
Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland
Search for other papers by Aldona Kowalska in
Google Scholar
PubMed
al . Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors . JAMA Oncology 2016 2 1023 – 1029 . ( https://doi.org/10.1001/jamaoncol.2016.0386 ) 5